Posts by drivendigital
LIGHT THE NIGHT 2017
Thank you to everyone who participated in the Leukemia and Lymphoma Society’s Light the Night Walk in! Thousands of people came out on Saturday night to support, celebrate, and remember those affected by blood cancer in the Sacramento area. We hope you grabbed a StemExpress water bottle by the Orchard gate and said hi if…
For More InformationSHARE YOUR STORY
What do you wish people knew about your condition? Illness and disease affect our lives in so many different ways, and no two experiences are the same. You could write about how you or a loved one has been affected by disease, why you chose to participate in medical research, or what you hope will…
For More InformationLUNG CANCER PROJECT
The ever-present goal of the StemExpress Foundation is to improve the lives and outcomes of patients with all kinds of diseases. To that end, we are excited to be participating in a new lung cancer project! Researchers have created a new diagnostic tool to detect lung cancer earlier and in a less invasive way than…
For More InformationWHAT THE FOUNDATION IS DOING IN OUR COMMUNITY
The StemExpress Foundation is supporting the Leukemia and Lymphoma Society at the Light the Night Walk, November fourth in Sacramento, CA. LLS is an incredible organization which provides hope and resources to people living with blood cancer across the United States, and supports research to end Leukemia and Lymphoma. Each Fall LLS holds the Light…
For More InformationSurvival and Proliferation of Human NK Cells in Humanized Mice
Natural killer (NK) cells play a critical role in the innate immune system and represent the first line of defense against pathogens and tumor cells. Involved in immune surveillance, NK cells patrol the body looking for infected or cancerous cells. While other immune cells recognize the presence of antibodies on the MHC receptor of infected…
For More InformationPotential of CRISPR-Cas9-based Technology to Treat Congenital Amegakaryocytic Thrombocytopenia (CAMT)
A single mutation in a gene can lead to rare inherited diseases, such as cystic fibrosis, Tay-Sachs, and sickle-cell anemia, and are often difficult to treat and, for most, have no cure. However, with the current advances in CRISPR-Cas9 genome engineering technology, it may be possible to introduce new immunotherapies to treat these and other…
For More InformationCGT Global Folsom Celebrates One Year Anniversary
It’s been one year since StemExpress moved our laboratory headquarters from Placerville to Folsom, CA. Our new state-of-the-art facility has enabled us to increase production and meet the growing needs of our clients. We thank our dedicated staff, the community of Folsom, and our clients for making the past year a successful one.
For More InformationDirected differentiation of human bone marrow MSCs to functional Schwann cells
The peripheral nervous system (PNS) comprises many complex cell types that work together to transmit electrical signals from the body’s sensory receptors to the central nervous system (CNS) and vice versa. Peripheral nerve cells relay the electrical signals through the long, thin part of the cell called an axon. Schwann cells create nodes of myelin…
For More InformationTreating the side effects of chemotherapy
The human body has many lines of defense against infection, keeping us healthy and free of disease. One immediate line of defense is the innate immune system, which is comprised of white blood cells that are ready to fight against bacterial or fungal infection at birth. One of the most numerous and important cells of…
For More InformationHow CAR-T cell therapy works
On August 30, 2017, the FDA approved the first US CAR-T cell therapy for the treatment of ALL patients. According to FDA Commissioner Dr. Scott Gottlieb, “We’re entering a new frontier in medical innovation with the ability to reprogram a patient’s own cells to attack a deadly cancer.” Check out this brief video about how…
For More Information